Apollo Micro Systems Ltd

Apollo Micro Sys Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Apollo Micro Systems Ltd

₹ 355 -0.99%
22 May - close price
apollo-micro.com BSE: 540879 NSE: APOLLO
About

Apollo Micro Systems Ltd is a pioneer in design, development, assembly and testing of electronic and electro mechanical solutions.[1]

Key Points

Service Offerings[1]
AMS is a leading technology provider of high-performance, mission-critical solutions for the defence sector. The company specializes in electronic, electromechanical, and engineering design, along with the manufacturing and supply of advanced systems. It provides wide range of strategic domains, including Missile Systems, Satellite and Space Systems, Naval Systems, Avionics, and Homeland Security.

It has 700+ onboard technologies and is actively involved in 150+ indigenous programs and 60 DcPP programs as a sub-system partner. It has presence in all Missile and Naval warfare programs. [2]

Website BSE NSE
  • Market Cap ₹ 12,716 Cr.
  • Current Price ₹ 355
  • High / Low ₹ 378 / 135
  • Stock P/E 113
  • Book Value ₹ 36.8
  • Dividend Yield 0.07 %
  • ROCE 14.5 %
  • ROE 11.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 61.6% CAGR over last 5 years

Cons

  • Stock is trading at 9.66 times its book value
  • Company has a low return on equity of 10.2% over last 3 years.
  • Promoters have pledged 39.9% of their holding.
  • Company has high debtors of 194 days.
  • Promoter holding has decreased over last 3 years: -7.12%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Industrials Capital Goods Aerospace & Defense Aerospace & Defense

Part of BSE Industrials Nifty Microcap 250 Nifty Total Market Nifty India Defence BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
107 58 87 91 135 91 161 148 162 134 225 252 293
84 45 69 67 107 69 128 110 126 93 166 202 226
Operating Profit 23 13 18 24 29 22 33 38 36 41 59 50 68
OPM % 21% 22% 21% 26% 21% 25% 20% 26% 22% 31% 26% 20% 23%
-1 0 0 0 1 1 1 1 1 1 1 1 3
Interest 8 8 7 7 8 8 7 9 11 12 13 14 9
Depreciation 3 3 3 3 3 3 4 4 4 4 5 6 7
Profit before tax 11 3 9 14 18 12 22 26 22 25 43 32 55
Tax % 36% 42% 25% 31% 29% 29% 30% 30% 36% 30% 30% 28% 33%
7 2 7 10 13 8 16 18 14 18 30 23 37
EPS in Rs 0.35 0.08 0.28 0.35 0.46 0.28 0.51 0.60 0.46 0.55 0.93 0.72 1.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
246 203 243 298 372 562 904
197 165 198 233 288 433 686
Operating Profit 49 39 46 64 84 129 218
OPM % 20% 19% 19% 22% 23% 23% 24%
2 1 1 -2 2 3 6
Interest 15 16 17 22 30 34 47
Depreciation 10 9 9 10 11 15 22
Profit before tax 25 14 20 29 44 83 155
Tax % 45% 29% 28% 35% 29% 32% 31%
14 10 15 19 31 56 107
EPS in Rs 0.67 0.49 0.70 0.90 1.10 1.84 3.16
Dividend Payout % 7% 5% 4% 3% 5% 14% 0%
Compounded Sales Growth
10 Years: %
5 Years: 35%
3 Years: 45%
TTM: 61%
Compounded Profit Growth
10 Years: %
5 Years: 62%
3 Years: 76%
TTM: 100%
Stock Price CAGR
10 Years: %
5 Years: 98%
3 Years: 119%
1 Year: 136%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 10%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 21 21 21 21 28 31 36
Reserves 275 284 299 363 490 576 1,277
83 117 116 144 208 335 543
86 110 164 165 230 357 512
Total Liabilities 465 532 599 693 956 1,299 2,369
50 49 86 106 144 182 477
CWIP 37 52 30 32 35 72 196
Investments 0 0 0 0 0 0 0
378 430 484 555 777 1,045 1,695
Total Assets 465 532 599 693 956 1,299 2,369

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
47 6 43 -16 -76 10 -130
-19 -23 -24 -35 -60 -91 -357
-36 17 -19 51 136 121 536
Net Cash Flow -8 0 0 -0 -0 40 49
Free Cash Flow 20 -16 21 -50 -131 -82 -357
CFO/OP 108% 24% 98% -21% -87% 13% -50%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 201 305 205 180 231 155 194
Inventory Days 421 546 597 594 612 553 478
Days Payable 115 189 258 195 239 258 230
Cash Conversion Cycle 507 661 544 579 605 450 443
Working Capital Days 312 372 314 319 348 253 256
ROCE % 8% 9% 11% 12% 14% 14%

Insights

In beta
Mar 2018 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
R&D Expenditure as % of Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Working Capital Cycle
Days
Indigenous Program Participation
Number ・Standalone data
Manufacturing Facility Area
sq ft ・Standalone data
On-board Technologies
Number ・Standalone data
Order Book
INR Millions
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

33 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
59.10% 52.67% 53.21% 53.21% 55.12% 55.12% 55.12% 55.12% 50.65% 50.33% 51.98% 51.98%
0.17% 5.27% 11.01% 11.14% 7.42% 0.19% 0.74% 0.93% 7.16% 8.94% 4.97% 3.63%
3.64% 3.31% 0.01% 0.01% 0.00% 0.87% 0.87% 0.37% 1.61% 1.45% 1.30% 1.82%
37.10% 38.76% 35.76% 35.62% 37.46% 43.82% 43.29% 43.60% 40.59% 39.27% 41.76% 42.58%
No. of Shareholders 59,53985,2061,43,7781,79,0492,15,5872,82,0552,86,0272,80,4273,05,6363,40,5113,60,1313,73,806

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls